Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SQUEEZE!
I actually see RED is quite probable today.
Care to explain WHY??
I see just the opposite! hehehehe
The rollover of the VIX combined with an 8 day reversal will likely set a nasty BEAR TRAP!!!
Any bets?
Yup, I'm in at 1.25 for a ride up to the 50MA. Very bullish momentum (measured by all metrics). Reversal bar in all indexes - including XBI. Greedy shorty gonna face a buz saw.
AMRN: my pick for a trading competition this week
**Triple bullish MACD divergence (1-2-3)
**Downthrust of the recent 4 month trading range to a 52-wk low on heavy volume (A)
**Impulse change to blue (B)
**Expanding daily range (A-B-C) on expanding volume
Entry: near mid-bar (1.23)
Exit: near the 50MA and or the high of the high-volume down bar on 8/22 (1.42 – 1.48)
Stop-loss: near the monthly range (yellow highlight / 1.14)
Expected gain: 15% - 20%
Reward/risk ratio: 2.8 (reward = .25 / potential Loss = .09)
Any trade setup with a R/R of over 2.0 is excellent. AMRN is 2.8.
“Fair weather poster”?
Well since you post satirical responses to every other post, does that make you a Diarrhea Poster?
IW - yes, I agree. Back on July 1, in response to MrMain's poll I wrote (post# 381938 for which I was ridiculed):
IW - congratulations on making money on the short side. Your trade would be a bit more impressive if you didn't feel the need to remind us all in bold print every 15 minutes. :)
well stated. Friday's news with the accompanying EU backdrop (entering a depression) does not bode well for the company over the next 12 months.
This is precisely why I continue to say this is a 'trade' and not an investment.
This new data didn't help the outcome of their decision;
Record jump in German producer prices adds to gloomy outlook
Nomura Warns "Apocalyptic" German PPI Triggers "Unclench" From "Gamma Gravity" Into OpEx
Near 40% German PPI cascades stocks, bonds and Euro selling through the session
IW - nice try. In your last post you wrote, " I'm thinking about continuing selling short." Now the price of AMRN is down AH on a Friday and all of a sudden you are short!? Haha.
BTW, I'm still trying to figure out how you made a profit covering your 65k shares short when the AMRN was at a 40 day high???
Kiwi, I agree. Interesting comparison: AMRN vs AUPH. The charts reflect the strength vs weakness
AMRN:
- price is > 50MA
- 20MA slope is up
- Impulse = blue and bullish MACD divergence
- Strong volume during recent rally / light volume on pullback to 50MA
AUPH:
- Price is < 50MA
- 20MA slope is down
- Impulse is red
- strong volume on the fallout of the 6 month trading range / light volume on the retest.
- Everything is in gear to the downside.
Bhatt's comment supports my theory that the efficacy of V in any current CV related trial will be amplified because of Covid and Covid vaccinations
This story is a crazy representation of how manipulated our markets are today:
Ryan Cohen Dumps Entire BBBY Stake, Makes $68 Million As Apes Crushed
This has had a ripple effect on all meme stocks which are down sharply.
I believe there's a strong possibility someone knows the results of MITIGATE and it is manifested it on the chart.
On Saturday 8/6/2022 I wrote:
Rhymes with other studies like this one, " this was a characteristic attributed to EPA rather than DHA" .
No I did not exit. This is the 2nd test of the 50MA in as many days. It is still a bullish daily pattern for me. Short it at your own risk
Hayward -
NS - you are right. I appreciate the information you and very few others share (even though I don't always agree with it).
There are a slug of old cranky posters who hover over their the keyboard, waiting to disagree to disagree or make some snide remark that attacks the message and the messenger. I wish they'd leave the board. They offer ZERO contribution. Like clockwork they creep out of the woodwork for a bite.
It's Bloomberg's chart. Sorry you'll have to check with them for statistical correlation.
Visual pattern correlation works just fine for me :)
Fair is fair... stupid losers are stupid losers - past or present!
TestyTheElf - losing it?
I get it... Sky's the limit, so you load up on call options that expire worthless. Then convert to a Roth IRA in anticipation of the stock going to 50... and it instead drops to 1.20.
Then some guy constantly posts charts that reminds you about 'woulda-coulda- shoulda' . No wonder you blast off on him. It's OK though, I cut you slack cause I love your sense of humor. :)
Well, let's look at my past posts and you tell me if I was correct in my 'big picture' view of AMRN:
This reversal was easy to see as it broke above the down trendline, accompanied by some very bullish synchronous TA events.
You mentioned you are holding 65kshares short. Holy moly...
Just because the stock has risen for 6 days (not 7) doesn't mean it will reverse on day 7 or 8 or 10. In fact, during spring market conditions, it is common to see 8-10 consecutive up days. Obviously 3,5,8 and 10 day reversals can vary widely based on momentum/accumulation patterns.
IMO, the chart above is very bullish and shows no sign of weakness. I'm expecting a sharp rally out of this squeeze pattern that takes prices to the Xtreme band around 1.80 before any stalling occurs
GLTU
Another trial finding that could increase sales that rival other indications:
new invitro-study shows encouraging link between epa and prostate cancer prevention
A few publications that should make the future bright for Vascepa
First, the adverse Covid effect on the brain:
Alzheimers like changes found in Covid Patients
Combined with this:
Eicosapentaenoic acid increases the degradation of amyloid-ß
Too many underestimate the effects of Covid-19 vaccines on event amplification in the control arm and the mitigating vaccine effect of V in the experimental arm of any current trial involving the cardio vascular system such as RESPECT, MITIGATE, or BRAVE.
The first to report will blow the top off IMO. I've always thought V would not receive wide spread recognition until there is more proof of broader inherent pleiotropic properties.
Once that genie's out... we'll see upgrades and 30.00/share in short order.